Number of shares and votes in Active Biotech

Number of shares and votes in Active Biotech

ID: 243992

(Thomson Reuters ONE) -


The number of shares and votes in Active Biotech has changed as a result of the
directed new issue to Investor as previously announced.

Today, the last trading day of the month, there are in total 74,923,582 shares
and votes in Active Biotech.


Lund, March 28, 2013
Active Biotech AB (publ)


For further information, please contact:
Hans Kolam, CFO
Tel: +46 (0)46 19 20 44
E-mail: hans.kolam(at)activebiotech.com

Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with
focus on autoimmune/inflammatory diseases and cancer. Projects in pivotal phase
are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, tasquinimod
for prostate cancer and ANYARA primarily for the treatment of renal cell cancer.
In addition, laquinimod is in Phase II development for Crohn's and Lupus. The
company also has one additional project in clinical development, the orally
administered compound 57-57 for Systemic Sclerosis. Please visit
www.activebiotech.com for more information.

Active Biotech AB (Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 46 19 20 00
Fax: +46 46 19 11 00

Active Biotech is required under the Financial Instruments Trading Act to make
the information in this press release public. The information was submitted for
publication at 08:30 a.m. CET on March 28, 2013.

Number of shares and votes in Active Biotech:
http://hugin.info/1002/R/1688517/553983.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and




originality of the information contained therein.

Source: Active Biotech via Thomson Reuters ONE
[HUG#1688517]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ING nominates Carin Gorter, Hermann-Josef Lamberti and  Isabel Martín Castellá as members of Supervisory Board VOLTA FINANCE - REPORT AND ACCOUNTS FOR THE SEMI-ANNUAL PERIOD ENDED 31 JANUARY 2013
Bereitgestellt von Benutzer: hugin
Datum: 28.03.2013 - 08:31 Uhr
Sprache: Deutsch
News-ID 243992
Anzahl Zeichen: 2292

contact information:
Town:

LUND



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 160 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Number of shares and votes in Active Biotech"
steht unter der journalistisch-redaktionellen Verantwortung von

Active Biotech (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Active Biotech's election committee appointed ...

In accordance with a decision made by the Annual General Meeting held on May 7, 2009, the Election Committee shall comprise the representatives for the three largest shareholders on September 30 and the Board Chairman. For the 2010 Annual General ...

Active Biotech AB Interim Report, January - September 2009 ...

* Laquinimod -- new data presented at ECTRIMS * 57-57 -- exploratory clinical trial in progress * RhuDex(TM) -- clinical development to continue following feedback from UK MHRA * ANYARA -- complete Phase I data published * TASQ -- complete Phase I ...

Alle Meldungen von Active Biotech



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z